05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2025

May 19, 2025, 15:42 | Blog
Mary Tanay: Happy European Cancer Nursing Day to All Fellow Nurses in Europe
Mary Tanay, Macmillan Consultant Nurse in Genomics at the Royal Berkshire NHS Foundation Trust, shared…
May 19, 2025, 15:41 | Blog
Swati Bhayana Announces Webinar on Tackling the BRAF Mutation in Neuro-Oncology
Swati Bhayana, Consultant at Fortis Healthcare, shared on X: "May is Brain Tumor Awareness Month…
May 19, 2025, 15:26 | Insight
New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM
MD Anderson Cancer Center shared a post on LinkedIn: "New research from MD Anderson shows…
May 19, 2025, 15:25 | Blog
AACR Opens Nominations for Lifetime Achievement Award in Cancer Research
AACR shared a post on X: "The AACR Award for Lifetime Achievement in Cancer Research…
May 19, 2025, 15:17 | Blog
Registration is Open for the Virtual Journal Club on NETTER-2 and KEYNOTE-826 Cancer Studies - ESMO
ESMO (European Society for Medical Oncology) shared a post on LinkedIn: "The latest studies on…
May 19, 2025, 14:20 | Blog
It’s Pink Monday: Your Reminder to Prioritize Your Health - Medicaid Cancer Foundation
Medicaid Cancer Foundation shared a post on LinkedIn: "It’s Pink Monday - your reminder to…
May 19, 2025, 14:10 | Blog
Debra Patt: Wellbeing and Experience Initiatives at COA Conference
Debra Patt, Chair of the AI Task Force and a Board Member for the American Society…
May 19, 2025, 14:00 | Blog
Valsamo Anagnostou: Our Blog Content Is Growing with Simplified Science and Educational Videos
Valsamo Anagnostou, Co-Director of Thoracic Oncology Precision Medicine Center of Excellence and Division of Upper Aerodigestive…
May 19, 2025, 13:59 | Blog
Vincent Rajkumar: How this most Notorious Drug on the Planet made an Incredible Comeback
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on X:…
May 19, 2025, 13:41 | Oncolibrary,Opinion
New Paper Alert: NO LIMIT Trial. First-Line Nivolumab Plus Low-Dose Ipilimumab in MSI-High Advanced Gastric and GEJ Cancer
The NO LIMIT (WJOG13320G) Phase II trial investigates a novel, chemotherapy-free first-line approach using nivolumab…
All: 2618 Posts: 911 - 920
Special Coverage